Developing Drugs and Diagnostic Tests for Integrated Cancer Management and Treatment of Neurodegenerative Diseases


Panacea's mission is to discover, develop and commercialize innovative therapeutic and diagnostic products for integrated cancer management as well as diseases of the central nervous system. Our current product development focus is on novel proteins and biochemical pathways related to cellular regulation and cell cycle abnormalities in oncology, as well as neurodegenerative diseases such as stroke, Alzheimer's, and Chemo-Brain.